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Francisella tularensis causes systemic disease in humans and other mammals, with high morbidity and
mortality associated with inhalation-acquired infection. F. tularensis is a facultative intracellular pathogen, but
the scope and significance of cell types infected during disease is unknown. Using flow cytometry, we identified
and quantified infected-cell types and assessed the impact of infection on cell populations following inhalation
of F. tularensis strains U112, LVS, and Schu S4. Initially, alveolar macrophages comprised over 70% of Schu
S4- and LVS-infected cells, whereas approximately 51% and 27% of U112-infected cells were alveolar macro-
phages and neutrophils, respectively. After 3 days, roughly half of Schu S4- and LVS- and nearly 80% of
U112-infected cells were neutrophils. All strains infected CD11bhigh macrophages, dendritic cells, monocytes,
and alveolar type II cells throughout infection. Macrophage, monocyte, and dendritic-cell populations were
reduced during U112 infection but not Schu S4 or LVS infection. These results demonstrate directly that F.
tularensis is a promiscuous intracellular pathogen in the lung that invades and replicates within cell types
ranging from migratory immune cells to structural tissue cells. However, the proportions of cell types infected
and the cellular immune response evoked by the human pathogenic strain Schu S4 differ from those of the
human avirulent U112.
Since 2001, there has been increased interest in understand-
ing pathogens with virulence characteristics that make them
dangerous for purposeful release. One such organism is the
gram-negative bacterium Francisella tularensis, the etiological
agent of tularemia. Virulent strains of Francisella can cause
incapacitating or lethal disease in humans, mice, and other
mammals (24). Tularemia can be acquired via insect bites (13),
by handling infected animal carcasses (30), from contaminated
water (11), or by inhalation (15). Inhalation exposure results in
the most-acute, rapidly progressing manifestation of disease
(6). When inhaled, as few as 10 organisms can cause a debili-
tating, and potentially fatal, infection in humans (22).
Given the seriousness of inhalation-acquired tularemia, sur-
prisingly little is known about Francisella biology in the host
lung. Within 1 hour after inhalation, Francisella is found in
airway macrophages and dendritic cells (DCs) (3, 4). However,
the infection of these cells does not trigger production of
tumor necrosis factor alpha or interleukin-6 (3, 4). Instead,
Francisella infection induces immunosuppressive mediators,
such as transforming growth factor  (TGF-) (3) and prosta-
glandin E2 (31), through yet-unknown mechanisms. F. tularen-
sis also infects other cell types important for host defense
against lung infections, such as monocytes (23), neutrophils
(16), and alveolar type II (ATII) epithelial cells (10).
Growth within host cells is recognized as an important as-
pect of Francisella pathogenesis; however, the range and scope
of cells infected throughout disease in an animal host have not
been determined. In order to understand the mechanisms piv-
otal to the virulence of this intracellular organism, it is impor-
tant to identify which cell types interact with the bacterium
during different stages of disease progression. Therefore, we
identified and quantified the repertoire of infected lung cells
and characterized the cellular immune response in mice fol-
lowing inhalation of three different F. tularensis subspecies.
MATERIALS AND METHODS
Bacterial culture. Francisella strains were maintained on chocolate agar sup-
plemented with Isovitalex (BD Biosciences). U112 was a gift from Colin Manoil,
LVS was obtained from the CDC in Atlanta, GA, and Schu S4 was obtained from
BEI Resources. Green fluorescent protein (GFP)-expressing strains contained a
modified pKK214gfp plasmid (a kind gift from Mats Forsman).
Mouse infections. Female 7- to 10-week-old C57BL/6 mice were inoculated
with Francisella strains diluted in sterile phosphate-buffered saline (PBS) and
enumerated by Klett reading or the optical density at 600 nm. Actual doses were
calculated from the average CFU of inoculums plated in triplicate. Mice were
anesthetized with avertin until unresponsive to toe pinch, and 50 l of
bacterial suspension was dispensed onto the nares of each mouse. The results
of previous studies demonstrated that roughly 20% of the inoculum CFU is
recovered from the lung 2 h postinoculation (8a) and that the procedure is
effective for establishing a pulmonary Francisella infection (10). All animal
experiments were conducted in accordance with animal care and use guide-
lines, and animal protocols were approved by the IACUC at UNC-Chapel
Hill.
Bacterial burden. The lungs were aseptically removed, and tissues were ho-
mogenized, diluted, and plated on chocolate agar to determine the bacterial
burden.
Lung cell isolation. The mice were anesthetized with avertin and heparin
(1,000 U/ml) and perfused with 4 to 7 ml of PBS and heparin (200 U/ml). The
tracheas were cannulated using a 16-gauge blunt-tipped needle, and the lungs
were inflated with approximately 1 ml of dispase (BD Biosciences). The tracheas
were tied off with surgical sutures, and the lungs were removed and incubated in
3.0 ml dispase at room temperature for 45 min. The tracheas were removed, the
lungs were transferred to a petri plate along with 7 ml of PBS-DNase I (250
g/ml), and the tissue was teased apart using forceps. The cells were gently
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swirled for 1 to 2 min, and the suspension was filtered through 40-m mesh. The
filtered suspensions were pelleted by centrifugation at 300  g for 5 min at 4°C
and resuspended in 1 ml red blood cell lysis solution for 2 min at room temper-
ature before 9 ml PBS was added to neutralize osmolarity. The cells were
pelleted, resuspended in PBS, and enumerated.
Cell sorting and fluorescence microscopy. Cell sorting was performed using a
MoFlo (Dako) cell sorter, and collected cells were dispensed onto poly-L-lysine-
coated glass coverslips and allowed to adhere for 1 h at 4°C. Cells were stained
with 4,6-diamidino-2-phenylindole (DAPI) mounting media, observed by using
a Zeiss Axioplan 2 epifluorescence microscope, and analyzed using SlideBook
digital deconvolution software (Intelligent Imaging Innovation).
Staining of lung cells for flow cytometry. Cells were kept on ice, and all
incubations were done at 4°C. To block Fc receptors, lung cells were incubated
in clone 2.4G2 culture supernatant for 20 min. Cells (106) were incubated with
the following fluorescently labeled antibodies to cell surface components: F4/80
phycoerythrin (clone BM8; eBioscience), GR-1 peridinin chlorophyll protein
(clone RB6-8C5; BD Biosciences), CD11b phycoerythrin-Cy7 (clone M1/70;
eBioscience), and CD11c Alexa 647 (clone N418; eBioscience) in flow buffer (1%
bovine serum albumin and 0.09% sodium azide in PBS) for 30 min. Cells were
washed with PBS and fixed with 4% paraformaldehyde in PBS for 30 min. Cells
were washed and resuspended in PBS and stored at 4°C until analysis by flow
cytometry.
Intracellular staining for ATII cells. 3C9 antibody (Abcam), which is specific
for LBM180 expressed in ATII cells (32), was labeled using an Alexa 647 Zenon
mouse immunoglobulin G2a antibody labeling kit (Invitrogen) according to the
manufacturer’s instructions. Lung cells were incubated in clone 2.4G2 culture
supernatant for 20 min to block Fc receptors, fixed, permeabilized with Cytofix/
Cytoperm buffer (BD Biosciences) for 30 min, and washed with Cytoperm buffer
(BD Biosciences). Permeabilized cells were incubated with labeled 3C9 antibody
in Cytoperm buffer for 30 min and washed with Cytoperm buffer before being
resuspended in PBS and stored at 4°C until analysis by flow cytometry.
Flow cytometry of lung cells and data analysis. Cells were analyzed using a
CyAn ADP LX 9 color flow cytometer (Dako). The data were analyzed using
Summit version 4.3 (Dako). Compensation was performed using lung cells
stained with each labeled antibody individually, and gates were drawn based on
n-1 controls. Data bars in figures represent the means of the results for 3 to 6
mice, and error bars represent the standard deviations of the means. Significance
was determined by using an unpaired two-tailed t test assuming unequal variance.
P values of  0.05 were characterized as significant.
Identifying lung cell types. Lung homogenates were treated with cell-type-
specific fluorescently labeled antibodies for the identification of cell populations.
The cell types we have defined as alveolar macrophages and DCs have the
phenotypic characteristics of these cell types (28). ATII cells were defined as
having high levels of expression of LBM180. No LBM180-expressing cells were
observed in splenocytes (data not shown), and 96% of cells staining positive for
LBM180 were GFP-positive (GFP) in an enhanced GFP/surfactant protein C
(SP-C) transgenic mouse (data not shown) in which GFP expression is driven by
the SP-C promoter, which is only active in ATII cells (20).
RESULTS
Identifying Francisella-infected lung cells. U112, live vaccine
strain (LVS), and Schu S4 are commonly studied, closely re-
lated F. tularensis strains that exhibit differences in host range,
virulence, and host response (Table 1). To directly compare
differences in pulmonary disease progression among Fran-
cisella strains, we sought to inoculate mice with a similar num-
ber of CFU for each strain. Mice were intranasally inoculated
with an average of 531 CFU of U112, 436 CFU of LVS, or 457
CFU of Schu S4. Twenty-four hours after inoculation, U112-
infected mice had the highest bacterial burden in the lungs
(6.74  105  3.89  105 CFU [mean  standard deviation]),
followed by Schu S4 (7.58  104  3.57  104 CFU) and LVS
(1.16  104  1.75  103 CFU) (Fig. 1A). By day 3, the lung
bacterial burden was greatest in Schu S4-infected (1.59  108 
1.11  108 CFU) mice, followed by U112-infected (6.97  107 
1.47  107 CFU) and LVS-infected (2.81  106  1.03  106
CFU) mice. These data indicate that U112 may have a faster
initial growth rate in the lung, but Schu S4 achieves the highest
bacterial burden by day 3.
To identify the host-cell niche occupied by these organisms,
single-cell suspensions from whole-lung digests of mice inocu-
TABLE 1. Comparison of Francisella tularensis strains
Parameter
Result for F. tularensis strain
U112 LVS Schu S4
Subspecies novicida holarctica tularensis
Genome (19)
Size (bp) 1,910,031 1,895,998 1,892,819
GC content (%) 32.47 32.15 32.26
No. of predicted open reading
frames
1731 1380 1445
No. of pseudogenes 14 303 254
Sequence similarities (%) of
common genes
97.8 to LVS, 98.1 to Schu S4 97.8 to U112, 99.2 to Schu S4 98.1 to U112, 99.2 to LVS
Intracellular replication occurs in:
Macrophages (2, 27; our
unpublished data)
Yes Yes Yes
ATII cells (10; our unpublished
data)
Yes Yes Yes
Virulence in mice (inhalation) (8, 17) High Moderate High
Virulence in humansa (inhalation)
(22, 26)
None reported Low High
Dissemination to distal organs
postinhalation (5, 8, 18; our
unpublished data)
Yes Yes Yes
Lethal inhalation dose in mice (7, 8;
our unpublished data)
10–100 500–5,000 10
a Data are for immunocompetent adults.
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FIG. 1. Identifying Francisella-infected lung cells. Lung cells infected with GFP Francisella are readily detectable by flow cytometry. Mice were
intranasally inoculated with GFP Francisella strains, and on days 1 and 3 postinoculation, lungs were harvested and digested to produce single-cell
suspensions which could be further analyzed. (A) Lung bacterial burden was determined for each strain at day 1 and day 3. (B) GFP lung cells
were detected on day 1 following intranasal inoculation with GFP LVS (LVSgfp). SSC, side scatter. (C) High-GFP, low-GFP, and GFP-negative
populations were collected and plated on coverslips for analysis by fluorescence microscopy. (D) The absolute numbers of GFP lung cells from
mice infected with U112, LVS, or Schu S4 were determined on day 1 and day 3 postinoculation. Error bars represent standard deviations of the
means (n 	 3 to 6 mice). Statistical significance of difference between results on day 1 and day 3 was determined by unpaired two-tailed t test
assuming unequal variance (*, P  0.05).
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lated intranasally with Francisella strains expressing GFP were
analyzed by flow cytometry and fluorescence microscopy.
GFP lung cells, indicating association with Francisella, were
readily detectable by flow cytometry (Fig. 1B). Microscopic
examination of cells sorted from the high-GFP population
presented significant punctate GFP fluorescence, indicative
of highly infected cells (Fig. 1C), whereas low-GFP cells had
as few as 1 GFP bacterium, indicating that cells containing a
single bacterium could be detected by flow cytometry. No
GFP bacteria were observed in the negative population. Pro-
jection images compiled from multiple planes throughout the z
axis of membrane-stained cells revealed that the bacteria were
intracellular (data not shown).
For each strain, there were more infected cells 24 h postin-
oculation than were in the initial inoculum, indicating that the
bacteria had replicated within this time frame (Fig. 1D). From
day 1 to day 3 postinhalation, there was a significant increase in
the number of infected lung cells for each strain (Fig. 1D). On
day 3, there were similar numbers of infected cells in mice
infected with U112 and Schu S4. Fewer GFP cells were ob-
served in LVS-infected mice at this time point.
Composition of the Francisella host cell niche. To assess the
suite of cells infected by Francisella following inhalation, we
identified GFP cells with cell-type-specific staining patterns
(Fig. 2 and Table 2). Twenty-four hours postinoculation, the
predominant infected-cell type in mice infected with U112
(51.6%), LVS (70.3%), and Schu S4 (78.9%) was alveolar
macrophages (Fig. 3). Other cell types infected at day 1 were
CD11bhigh macrophages (11.0% for U112, 9.0% for LVS, and
6.2% for Schu S4), CD11blow/mid DCs (1.2% for U112, 10.6%
for LVS, and 2.0% for Schu S4), and ATII cells (2.4% for
U112, 5.1% for LVS, and 6.0% for Schu S4). Only 0.4% of
LVS-associated cells were neutrophils and no Schu S4-associ-
ated neutrophils were observed on day 1. In contrast, 27.3% of
U112-infected cells at day 1 were neutrophils.
By day 3, neutrophils were the most-common infected-cell
type for each strain (79.3% for U112, 45.0% for LVS, and
56.2% for Schu S4), although they were more prevalent in
U112-infected mice (Fig. 3). The percentage of infected cells
that were alveolar macrophages decreased to 2.3% for U112,
23.5% for LVS, and 14.3% for Schu S4. We observed a higher
fraction of CD11blow/mid DCs among LVS-infected cells than
FIG. 2. Identifying cell types in the lung by flow cytometry. Cell types were identified based on differential expression of F4/80, CD11b, CD11c,
and GR-1. Mouse lungs were digested with dispase, and cells were stained with fluorescently labeled cell-type-specific antibodies. (A, B) F4/80
cells (A) that were CD11blow (B) were classified as alveolar macrophages, while F4/80high CD11bhigh cells were classified as CD11bhigh macro-
phages. (C) F4/80low CD11chigh cells were classified as DCs and subdivided into CD11blow/mid DCs and CD11bhigh DCs. F4/80low CD11clow
CD11bmid cells were classified as monocytes. (D) F4/80low CD11clow CD11bhigh GR-1high cells were classified as neutrophils.
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for either of the other strains. Also, a greater proportion of
Schu S4-infected cells (8.8%) than of LVS- (1.6%) or U112-
infected cells (1.4%) at day 3 were monocytes.
Numbers of infected cells. Examining the proportions of
Francisella-infected-cell types in the lung gave us insight into
the Francisella host cell suite over time, but another important
consideration for understanding inhalation tularemia is how
the abundance of infected cells changes in the lung during the
course of disease. Therefore, we quantified the number of each
cell type infected at days 1 and 3 following inhalation. There
were significant increases in the numbers of infected
CD11bhigh macrophages, CD11bhigh DCs, monocytes, neutro-
phils, and ATII cells in mice infected with each strain between
day 1 and day 3 (Fig. 4B, D, E, F, and G). In contrast, the
number of infected alveolar macrophages and CD11blow/mid
DCs increased from day 1 to day 3 in mice infected with LVS
or Schu S4, whereas the number of these cells infected with
U112 was unchanged (Fig. 4A and C). Most strikingly, on day
1 following inoculation, there were 2,670  1,287 U112-in-
fected neutrophils compared to 19  17 for LVS and none
detected for Schu S4. (Fig. 4F). These data demonstrate that
increasing numbers of alveolar macrophages and DCs con-
tinue to become infected from day 1 to day 3 following inha-
lation of LVS or Schu S4 but not during infection with U112.
Schu S4-infected lungs had more infected monocytes than
U112- or LVS-infected lungs, indicating a potential propensity
by this strain to infect these cells.
Effects on cell populations during disease progression. In
addition to analyzing the numbers and proportions of infected-
cell types, we determined how Francisella infections impacted
total cell populations in the lung as disease progressed. Strain
U112 caused a 2.4-fold decrease in the number of alveolar
macrophages from day 1 to day 3 (Fig. 5A). The alveolar
macrophage numbers in LVS- or Schu S4-infected mice did
not change significantly from day 1 to day 3.
Similar to alveolar macrophages, DC populations decreased
significantly from day 1 to day 3 in U112-infected mice (Fig. 5C
and D). CD11blow/mid DCs decreased 2.3-fold and CD11bhigh
DCs decreased 1.8-fold from day 1 to day 3 in U112-infected
mice. There was no significant change in the number of DCs in
LVS- or Schu S4-infected mice from day 1 to day 3. Also, no
difference was observed between the numbers of DCs from
infected mice and PBS control mice at day 1.
There was no significant difference in the number of mono-
cytes on day 1 following infection with each strain and the
TABLE 2. Identification of specific cell types from
lung homogenates
Cell type Propertiesa
Alveolar macrophage ..........F4/80high CD11blow CD11chigh GR-1low
FShigh SShigh
CD11bhigh Macrophage ......F4/80high CD11bhigh CD11cvar GR-1low
FSvar SSvar
CD11blow/mid DC .................F4/80low CD11blow/mid CD11chigh GR-1low
FSmid SSmid




Neutrophil ............................F4/80low CD11bhigh CD11clow GR-1high
FSvar SSvar
ATII epithelial .....................LBP18high FSmid SShigh (low for other
markers)
a FS, forward light scatter; SS, side light scatter; mid, medium level; var,
variable level.
FIG. 3. Lung cell types infected by Francisella following inhalation. Proportions of lung cell types infected with Francisella strain U112, LVS,
or Schu S4 on day 1 and day 3 postinoculation.
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number in PBS control mice (Fig. 5E). The number of mono-
cytes in LVS- and Schu S4-infected mice increased significantly
from day 1 to day 3, whereas U112-infected mice had fewer
monocytes in the lung over time.
Lungs from LVS- and Schu S4-infected mice had more
CD11bhigh macrophages at day 3 than day 1, while U112-
infected mice displayed no significant change in CD11bhigh
macrophage numbers (Fig. 5B). Considering that alveolar
macrophage, DC, and monocyte populations decreased in re-
sponse to U112 infection by day 3, it is plausible that there is
a balance between macrophage recruitment to the lung and
macrophage killing which would result in no net change from
FIG. 4. Numbers of Francisella-infected cells following inhalation. Absolute numbers of infected alveolar macrophages (A), CD11bhigh
macrophages (B), CD11blow/mid DCs (C), CD11bhigh DCs (D), monocytes (E), neutrophils (F), and ATII cells (G) from mouse lungs on day 1 and
day 3 following intranasal inoculation with U112, LVS, or Schu S4. Error bars represent standard deviations of the means (n 	 3 to 6 mice).
Statistical significance of difference between results on day 1 and day 3 was determined by unpaired two-tailed t test assuming unequal variance.
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day 1 to day 3, though more experimental work is needed to
determine if this is the case. There was no difference between
the number of CD11bhigh macrophages in infected lungs and
lungs from PBS control mice at day 1.
In response to Francisella infection, there was a significant
increase in the number of neutrophils in the lungs of mice
infected by each strain from day 1 to day 3 (Fig. 5F), indicating
that infection resulted in neutrophil recruitment, but not until
at least 24 h following exposure. One day postinhalation, there
were no increases in the numbers of neutrophils in the lungs of
infected mice compared to the number in PBS-inoculated con-
trol mice. We consistently observed fewer neutrophils at day 1
in Schu S4-infected mice than in PBS control mice (P  0.05),
suggesting that Schu S4 may initially suppress neutrophil re-
cruitment more efficiently than U112 or LVS.
Unlike other cell types analyzed, ATII cells are stationary
structural cells. As expected, there was no significant change in
the number of ATII cells in response to Francisella infection by
FIG. 5. Effects of Francisella infection on cell numbers within lung populations. Absolute numbers of alveolar macrophages (A), CD11bhigh
macrophages (B), CD11blow/mid DCs (C), CD11bhigh DCs (D), monocytes (E), neutrophils (F), and ATII cells (G) from mouse lungs on day 1 and
day 3 following intranasal inoculation with U112, LVS, or Schu S4. Error bars represent standard deviations of the means (n 	 3 to 6 mice).
Statistical significance of difference between day 1 and day 3 was determined by unpaired two-tailed t test assuming unequal variance.
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U112, LVS, or Schu S4 from day 1 to day 3 (Fig. 5G), but these
studies do not address any effects that infection may have on
ATII cell physiology or function.
Taken together, these data demonstrate that, with regard to
cell recruitment, the innate immune response to LVS and Schu
S4 in the lung is similar despite differences in the lethal dose
of each strain. Upon inhalation, Francisella infects a variety
of host cells, though alveolar macrophages are the predom-
inant infected cell early during infection while neutrophils
are recruited and become the main host cell in the later
stages of pulmonary tularemia. U112 differed from both
LVS and Schu S4 in that it was taken up by neutrophils more
rapidly following inhalation, and this apparently occurs
without significant recruitment of new neutrophils to the
lung. U112 infection also affected macrophage, DC, and
monocyte populations differently during the course of dis-
ease than LVS or Schu S4.
Dose effects on host cell response and infected-cell popula-
tions. In order to reproducibly detect infected-cell populations
in the early stages of infection, it was necessary to inoculate
animals with a dose of at least 400 CFU. Since this dose
represents at least a 10-fold increase over the 100% lethal dose
of Schu S4, we wanted to determine if the magnitude of the
inoculum impacted host cell infiltration or the composition of
infected-cell types over time. Mice were inoculated intranasally
with 42 CFU of GFP Schu S4. Infected- and uninfected-host-
cell populations were quantified 3 days postinoculation, and
the results compared to those for 3-day-infected animals that
received the 10-fold-higher dose. Not surprisingly, there were
more infected cells of each type in the high-dose-inoculated
mice, but the proportions of infected-cell types resulting from
the different doses were essentially the same (Table 3). There
were differences in the total numbers of some cell types
present in the lungs of the high- and low-dose-inoculated an-
imals. Specifically, there were 2.08-fold  0.89-fold more neu-
trophils and 2.01-fold  0.12-fold more CD11bhigh DCs in
mice infected with the higher dose of Schu S4. Interestingly,
there were almost twofold more CD11bhigh macrophages in
mice infected with the lower Schu S4 dose. These data indicate
that the magnitude of the dose primarily affected the absolute
numbers of infected cells but not the proportions of infected-
cell types or the magnitude of the cellular response to Fran-
cisella infection in the lung.
DISCUSSION
A goal of this study was to determine which cells in the lung
become infected by F. tularensis following inhalation and iden-
tify how these populations are altered during pulmonary tula-
remia. At the same time, we sought to compare three com-
monly studied Francisella strains with regard to cell infection
and impact on cell population dynamics in the lung. Under-
standing the similarities and differences among strains will
enable more-accurate interpretations of the results of other
studies using these strains, as well as facilitate more-specific
inquiries into Francisella disease mechanisms.
To directly compare lung infections by Francisella strains, we
initiated infection with similar numbers of each strain. Our
dose range allowed the detection of infected-cell types from
whole-lung digests 24 h postinoculation. Infected cells from
mice inoculated with less than 100 bacteria were not consis-
tently distinguished from the background at day 1. However,
mice infected in a similar way with a low dose of Schu S4
displayed a suite of infected cells and recruitment of mono-
cytes and neutrophils at day 3 similar to those in mice inocu-
lated with 400 CFU, indicating that the host response in the
lung at a higher dose was not appreciably different from the
response to a very low dose, with the exception of the total
number of infected cells.
During the early stages of infection, LVS- and Schu S4-
mediated disease appeared similar, while U112-mediated dis-
ease displayed fundamental differences. The most-common in-
fected-cell type 24 h after inhalation of each strain was alveolar
macrophages, although CD11bhigh macrophages, CD11blow/mid
DCs, and ATII cells were also infected. In contrast, U112 was
found in neutrophils at 24 h but LVS and Schu S4 were not.
While there was no apparent influx of neutrophils overall at
this stage of infection, there were over 1,000-fold more neu-
trophils associated with U112 than with LVS or Schu S4, in-
dicating that neutrophils responded to and phagocytosed U112
to a significantly greater extent than they did LVS or Schu S4.
Also, U112-infected mice lost alveolar macrophages, DCs,
and monocytes during the course of disease, whereas depletion
of these cell types was not observed in LVS- or Schu S4-
infected mice. Potentially, phagocytes that are infected in the
early stages of disease begin to undergo apoptosis or necrosis
by day 3. More studies are needed to determine if U112 infec-
tion results in more-rapid killing of infected cells than infection
by LVS or Schu S4.
Other studies have noted differences in U112 compared to
LVS or Schu S4. For example, “F. tularensis subspecies novi-
cida” (U112) exhibits different immunostimulatory properties
in a mammalian host than F. tularensis subspecies holarctica
(LVS) or tularensis (Schu S4). U112 lipopolysaccharide (LPS)
stimulates macrophages to produce proinflammatory cyto-
kines, such as tumor necrosis factor alpha, which are important
in signaling the recruitment of neutrophils and monocytes,
whereas LPS of LVS and Schu S4 does not (21). We therefore
might have expected that U112 would provoke a more-rapid or
-robust neutrophil influx than LVS or Schu S4, but this was not
the case. Though significantly more U112 organisms than LVS
or Schu S4 organisms were observed in neutrophils early dur-
ing infection, there was no difference between the abundance
of neutrophils in U112-infected lungs and their abundance in
TABLE 3. Comparison of infected and total cell populations from
mice infected with 400 CFU versus 40 CFU of Schu S4
Cell type
Ratio for mice infected with 400 CFU/
mice infected with 40 CFUa
Infected cells Total cells
Alveolar macrophage 3.66  2.25 1.24  0.41
CD11bhigh macrophage 7.90  6.97 0.82  0.16
CD11blow/mid DC 3.72  1.29 0.52  0.02
CD11bhigh DC 10.80  4.42 2.01  0.12
Monocyte 16.03  6.78 1.20  0.37
Neutrophil 34.81  13.44 2.08  0.89
ATII epithelial 13.11  3.46 0.85  0.24
a Numbers represent means  standard deviations.
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lungs infected with the other strains or in lungs of PBS control
mice. A different study reported that inhalation of U112 did
not lead to neutrophil recruitment in the lung after 4 h (9),
which is similar to our observations at 24 h. In addition to
neutrophil recruitment, we observed an increase in the number
of monocytes in LVS- and Schu S4-infected mouse lungs; how-
ever, the number of these cells in U112-infected mice de-
creased. Different studies are needed to determine whether
monocyte recruitment is being blocked by U112 or whether
these cells are being killed at a more-rapid rate than they are
recruited.
Francisella’s high capacity to cause disease in mammals is
not entirely explained by lack of host recognition. Francisella-
infected macrophages are unable to respond to proinflamma-
tory stimuli, such as E. coli LPS (25), indicating an active
suppression of this response. Though the complete mechanism
for inflammatory cytokine suppression is unclear, there is ev-
idence that LVS and Schu S4 stimulate production of the
immunosuppressive cytokine TGF- within infected pulmo-
nary macrophages and DCs (3, 4). TGF- leads to upregula-
tion of Fc receptor on macrophages, which increases the
phagocytic capability of these cells (29) and at the same time
limits the production of gamma interferon and other proin-
flammatory molecules (12). Normally, increased phagocytosis
by macrophages would expedite the clearance of bacterial in-
fection. However, given Francisella’s ability to survive and rep-
licate within these cells, this may exacerbate the replication of
the organism within the host. While the production of TGF-
and other immunosuppressive mediators may delay the influx
of inflammatory cells, the results of this study demonstrate that
eventual neutrophil and monocyte recruitment did occur in
response to Francisella infection in the lung; however, these
cells contribute to the progression of the disease by becoming
host cells for Francisella replication.
Normally, neutrophils are key to controlling bacterial infec-
tions with a significant intramacrophage-growth component
(14). Despite the evolution of neutrophils as efficient microbial
killers, the data presented here demonstrate that interactions
with neutrophils are a key component of Francisella pathogen-
esis within the lung. The results of recent in vitro studies
demonstrated that LVS is rapidly taken up by human neutro-
phils, but the respiratory burst is prevented due to disruption
of NADPH oxidase assembly within the phagosome. This pro-
cess is apparently due to an undefined active bacterial process,
as Francisella infection also prevented neutrophils from re-
sponding to potent heterologous stimuli (1, 16).
Another observation from this study was that infected ATII
cells, which are nonmigratory, were as abundant as infected
DCs or interstitial macrophages during the early stages of
disease. Francisella interactions with ATII cells could play a
unique role in pulmonary tularemia. Cell-cell junctions of the
epithelium and endothelium are affected by infection-induced
cytokines and chemokines which facilitate chemotaxis of neu-
trophils and monocytes from the bloodstream to infected tis-
sue. The alveolar epithelium is closely associated with blood
vessels to provide efficient oxygen exchange, and in addition to
facilitating inflammatory-cell recruitment into the lung, in-
creasing numbers of Francisella within ATII cells during dis-
ease progression could provide a method of bacterial entry into
the bloodstream. In this way, ATII cells could provide a “gate-
way” to the bloodstream where bacteria could then dissemi-
nate to distal organs, such as the liver and spleen. Further
studies are ongoing in our lab to decipher the unique contri-
bution of ATII cells during inhalation-acquired tularemia.
ACKNOWLEDGMENTS
We thank Jo Rae Wright for helpful advice and for providing pro-
SP-C/enhanced GFP mice. We also thank James Fuller and Todd
Kijek for helpful assistance in preparing the manuscript.
This work was supported by a Southeast Regional Center of Excel-
lence in Biodefense and Emerging Infections grant (NIH/NIAID U54-
AI057157) and by the National Institutes of Health (1R56-AI069339).
REFERENCES
1. Allen, L. A., and R. L. McCaffrey. 2007. To activate or not to activate: distinct
strategies used by Helicobacter pylori and Francisella tularensis to modulate
the NADPH oxidase and survive in human neutrophils. Immunol. Rev.
219:103–117.
2. Anthony, L. D., R. D. Burke, and F. E. Nano. 1991. Growth of Francisella spp.
in rodent macrophages. Infect. Immun. 59:3291–3296.
3. Bosio, C. M., H. Bielefeldt-Ohmann, and J. T. Belisle. 2007. Active suppres-
sion of the pulmonary immune response by Francisella tularensis Schu4.
J. Immunol. 178:4538–4547.
4. Bosio, C. M., and S. W. Dow. 2005. Francisella tularensis induces aberrant
activation of pulmonary dendritic cells. J. Immunol. 175:6792–6801.
5. Conlan, J. W., X. Zhao, G. Harris, H. Shen, M. Bolanowski, C. Rietz, A.
Sjostedt, and W. Chen. 2008. Molecular immunology of experimental pri-
mary tularemia in mice infected by respiratory or intradermal routes with
type A Francisella tularensis. Mol. Immunol. 45:2962–2969.
6. Ellis, J., P. C. Oyston, M. Green, and R. W. Titball. 2002. Tularemia. Clin.
Microbiol. Rev. 15:631–646.
7. Eyles, J. E., M. G. Hartley, T. R. Laws, P. C. Oyston, K. F. Griffin, and R. W.
Titball. 2008. Protection afforded against aerosol challenge by systemic im-
munisation with inactivated Francisella tularensis live vaccine strain (LVS).
Microb. Pathog. 44:164–168.
8. Fortier, A. H., M. V. Slayter, R. Ziemba, M. S. Meltzer, and C. A. Nacy. 1991.
Live vaccine strain of Francisella tularensis: infection and immunity in mice.
Infect. Immun. 59:2922–2928.
8a.Fuller, J. R., R. R. Craven, J. D. Hall, T. M. Kijek, S. Taft-Benz, and T. H.
Kawula. 2008. RipA, a cytoplasmic membrane protein conserved among
Francisella species, is required for intracellular survival. Infect. Immun. 76:
4934–4943.
9. Hajjar, A. M., M. D. Harvey, S. A. Shaffer, D. R. Goodlett, A. Sjostedt, H.
Edebro, M. Forsman, M. Bystrom, M. Pelletier, C. B. Wilson, S. I. Miller,
S. J. Skerrett, and R. K. Ernst. 2006. Lack of in vitro and in vivo recognition
of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.
Infect. Immun. 74:6730–6738.
10. Hall, J. D., R. R. Craven, J. R. Fuller, R. J. Pickles, and T. H. Kawula. 2007.
Francisella tularensis replicates within alveolar type II epithelial cells in vitro
and in vivo following inhalation. Infect. Immun. 75:1034–1039.
11. Leblebicioglu, H., S. Esen, D. Turan, Y. Tanyeri, A. Karadenizli, F. Ziyagil,
and G. Goral. 2008. Outbreak of tularemia: a case-control study and envi-
ronmental investigation in Turkey. Int. J. Infect. Dis. 12:265–269.
12. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by
TGF-beta. Annu. Rev. Immunol. 16:137–161.
13. Lopez, C. E., A. N. Kornblatt, R. K. Sikes, and O. E. Hanes. 1982. Tularemia:
review of eight cases of tick-borne infection and the epidemiology of the
disease in Georgia. South. Med. J. 75:405–407.
14. Mandic-Mulec, I., J. Weiss, and A. Zychlinsky. 1997. Shigella flexneri is
trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. In-
fect. Immun. 65:110–115.
15. Matyas, B. T., H. S. Nieder, and S. R. Telford III. 2007. Pneumonic tularemia
on Martha’s Vineyard: clinical, epidemiologic, and ecological characteristics.
Ann. N. Y. Acad. Sci. 1105:351–377.
16. McCaffrey, R. L., and L. A. Allen. 2006. Francisella tularensis LVS evades
killing by human neutrophils via inhibition of the respiratory burst and
phagosome escape. J. Leukoc. Biol. 80:1224–1230.
17. Owen, C. R., E. O. Buker, W. L. Jellison, D. B. Lackman, and J. F. Bell. 1964.
Comparative studies of Francisella tularensis and Francisella novicida. J.
Bacteriol. 87:676–683.
18. Pammit, M. A., V. N. Budhavarapu, E. K. Raulie, K. E. Klose, J. M. Teale,
and B. P. Arulanandam. 2004. Intranasal interleukin-12 treatment promotes
antimicrobial clearance and survival in pulmonary Francisella tularensis
subsp. novicida infection. Antimicrob. Agents Chemother. 48:4513–4519.
19. Rohmer, L., C. Fong, S. Abmayr, M. Wasnick, T. J. Larson Freeman, M.
Radey, T. Guina, K. Svensson, H. S. Hayden, M. Jacobs, L. A. Gallagher, C.
Manoil, R. K. Ernst, B. Drees, D. Buckley, E. Haugen, D. Bovee, Y. Zhou,
J. Chang, R. Levy, R. Lim, W. Gillett, D. Guenthener, A. Kang, S. A. Shaffer,
VOL. 76, 2008 FRANCISELLA INTERACTIONS WITH HOST LUNG CELLS 5851
G. Taylor, J. Chen, B. Gallis, D. A. D’Argenio, M. Forsman, M. V. Olson,
D. R. Goodlett, R. Kaul, S. I. Miller, and M. J. Brittnacher. 2007. Compar-
ison of Francisella tularensis genomes reveals evolutionary events associated
with the emergence of human pathogenic strains. Genome Biol. 8:R102.
20. Roper, J. M., R. J. Staversky, J. N. Finkelstein, P. C. Keng, and M. A.
O’Reilly. 2003. Identification and isolation of mouse type II cells on the basis
of intrinsic expression of enhanced green fluorescent protein. Am. J. Physiol.
Lung Cell Mol. Physiol. 285:L691–L700.
21. Sandstrom, G., A. Sjostedt, T. Johansson, K. Kuoppa, and J. C. Williams.
1992. Immunogenicity and toxicity of lipopolysaccharide from Francisella
tularensis LVS. FEMS Microbiol. Immunol. 5:201–210.
22. Saslaw, S., H. T. Eigelsbach, J. A. Prior, H. E. Wilson, and S. Carhart. 1961.
Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107:
702–714.
23. Schulert, G. S., and L. A. Allen. 2006. Differential infection of mononuclear
phagocytes by Francisella tularensis: role of the macrophage mannose re-
ceptor. J. Leukoc. Biol. 80:563–571.
24. Sjostedt, A. 2007. Tularemia: history, epidemiology, pathogen physiology,
and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1–29.
25. Telepnev, M., I. Golovliov, T. Grundstrom, A. Tarnvik, and A. Sjostedt. 2003.
Francisella tularensis inhibits Toll-like receptor-mediated activation of in-
tracellular signalling and secretion of TNF-alpha and IL-1 from murine
macrophages. Cell. Microbiol. 5:41–51.
26. Tigertt, W. D. 1962. Soviet viable Pasteurella tularensis vaccines. A review of
selected articles. Bacteriol. Rev. 26:354–373.
27. Twine, S., M. Bystrom, W. Chen, M. Forsman, I. Golovliov, A. Johansson, J.
Kelly, H. Lindgren, K. Svensson, C. Zingmark, W. Conlan, and A. Sjostedt.
2005. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to
express a 58-kilodalton protein is attenuated for virulence and is an effective
live vaccine. Infect. Immun. 73:8345–8352.
28. Vermaelen, K., and R. Pauwels. 2004. Accurate and simple discrimination of
mouse pulmonary dendritic cell and macrophage populations by flow cytom-
etry: methodology and new insights. Cytometry A 61:170–177.
29. Welch, G. R., H. L. Wong, and S. M. Wahl. 1990. Selective induction of Fc
gamma RIII on human monocytes by transforming growth factor-beta. J. Im-
munol. 144:3444–3448.
30. Wherry, W. B., and B. H. Lamb. 2004. Infection of man with Bacterium
tularense. 1914. J. Infect. Dis. 189:1321–1329.
31. Woolard, M. D., J. E. Wilson, L. L. Hensley, L. A. Jania, T. H. Kawula, J. R.
Drake, and J. A. Frelinger. 2007. Francisella tularensis-infected macro-
phages release prostaglandin E2 that blocks T cell proliferation and pro-
motes a Th2-like response. J. Immunol. 178:2065–2074.
32. Zen, K., K. Notarfrancesco, V. Oorschot, J. W. Slot, A. B. Fisher, and H.
Shuman. 1998. Generation and characterization of monoclonal antibodies to
alveolar type II cell lamellar body membrane. Am. J. Physiol. 275:L172–
L183.
Editor: W. A. Petri, Jr.
5852 HALL ET AL. INFECT. IMMUN.
